The efficacy and safety of Mirogabalin for chronic pain derived from neuropathic pai
Not Applicable
- Conditions
- Chronic pain, Neuropathic pain
- Registration Number
- JPRN-UMIN000037216
- Lead Sponsor
- TT Medical Center Tokyo Department of Pain clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 257
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who cannot answer questionnaires
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RS(Numerical rating scale) is assessed at, before perscription, in 2 weeks, and in 1/2/3/6 months.
- Secondary Outcome Measures
Name Time Method Side effects and QOL scores are assessed, before perscription, in 2 weeks, and in 1/2/3/6 months.